FR3097743B1 - Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme - Google Patents
Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme Download PDFInfo
- Publication number
- FR3097743B1 FR3097743B1 FR1907136A FR1907136A FR3097743B1 FR 3097743 B1 FR3097743 B1 FR 3097743B1 FR 1907136 A FR1907136 A FR 1907136A FR 1907136 A FR1907136 A FR 1907136A FR 3097743 B1 FR3097743 B1 FR 3097743B1
- Authority
- FR
- France
- Prior art keywords
- combination product
- help maintain
- natural defenses
- vitamin
- defenses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013066 combination product Substances 0.000 title abstract 3
- 229940127555 combination product Drugs 0.000 title abstract 3
- 230000037125 natural defense Effects 0.000 title abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 244000133098 Echinacea angustifolia Species 0.000 abstract 1
- 241000241413 Propolis Species 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 235000014134 echinacea Nutrition 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940069949 propolis Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La présente invention a pour objet un produit de combinaison comprenant à titre de substances actives, au moins de l’échinacée, de la propolis, de la vitamine C et de la vitamine D3 dans une forme sèche pour aider au maintien des défenses naturelles de l’organisme. L'invention concerne enfin l'utilisation d'un produit de combinaison tel que précédemment défini pour la prévention et/ou le traitement des pathologies infectieuses, qu’elles soient d’origine virale ou bactérienne.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1907136A FR3097743B1 (fr) | 2019-06-28 | 2019-06-28 | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme |
| PCT/EP2020/067904 WO2020260500A1 (fr) | 2019-06-28 | 2020-06-25 | Produit de combinaison pour aider au maintien des défenses naturelles de l'organisme |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1907136 | 2019-06-28 | ||
| FR1907136A FR3097743B1 (fr) | 2019-06-28 | 2019-06-28 | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3097743A1 FR3097743A1 (fr) | 2021-01-01 |
| FR3097743B1 true FR3097743B1 (fr) | 2023-11-24 |
Family
ID=69104501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1907136A Active FR3097743B1 (fr) | 2019-06-28 | 2019-06-28 | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR3097743B1 (fr) |
| WO (1) | WO2020260500A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3125712A1 (fr) * | 2021-07-30 | 2023-02-03 | Urgo Recherche Innovation Et Developpement | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme, à la protection des cellules contre le stress oxydatif et réduire la fatigue |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028258A1 (en) * | 2000-05-09 | 2002-03-07 | Pharmanex, Llc | Immunostimulant compositions and associated methods |
| IT1397225B1 (it) * | 2009-12-30 | 2013-01-04 | Nm Tech Nanomaterials And Microdevices Technology Ltd | Composizione battericida e virucida per il cavo orale |
| EA201590568A1 (ru) * | 2012-10-17 | 2015-09-30 | Монтеро Гида Санайи Ве Тиджарет А.С. | Составы, содержащие экстракты растений |
| WO2018136490A1 (fr) * | 2017-01-17 | 2018-07-26 | M. Alphabet 3, Llc | Compositions et procédés pour rhume banal |
| US10149831B1 (en) * | 2017-10-19 | 2018-12-11 | Edward Wick | Pharmaceutical composition for treating bacterial and viral infections |
-
2019
- 2019-06-28 FR FR1907136A patent/FR3097743B1/fr active Active
-
2020
- 2020-06-25 WO PCT/EP2020/067904 patent/WO2020260500A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| FR3097743A1 (fr) | 2021-01-01 |
| WO2020260500A1 (fr) | 2020-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017014088A2 (pt) | aparelho dentário que fornece superfícies oclusais expostas | |
| TNSN91029A1 (fr) | Les analogues du nucleoside de 1,3-oxathiolane | |
| MA27334A1 (fr) | Utilisation d'inhibiteurs de l'ikb kinase dans le traitement de la douleur | |
| MA50406B1 (fr) | Inhibiteurs pyrazole de magl | |
| MA43113B1 (fr) | Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci | |
| MA57226A1 (fr) | Méthodes de traitement d'une splénomégalie | |
| CL2020000491A1 (es) | Métodos para aumentar y/o estabilizar la función cardiaca en pacientes con enfermedad de fabry. | |
| FR3097743B1 (fr) | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme | |
| MA30035B1 (fr) | Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane | |
| MA39447B1 (fr) | Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
| FR2885491B1 (fr) | Traitement de la secheresse keratinique par des glycerides | |
| FR3097744B1 (fr) | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme | |
| MA54936A (fr) | Triamtérène ou nolatrexed destinés à être utilisés dans le traitement de la phénylcétonurie | |
| MA29145B1 (fr) | Préparations pharmaceutiques pour le traitement de la cellulite | |
| FR3099698B1 (fr) | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme | |
| MA54276B1 (fr) | Montélukast destinée au traitement de l'arthrose de la main | |
| MA39406A1 (fr) | Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline | |
| MA46778B1 (fr) | Composition intranasale comprenant de la bétahistine | |
| FR2823977B1 (fr) | Utilisation du mangafodipir dans le traitement des effets d'un stress oxydatif | |
| FR2898059B1 (fr) | Composition phytohormonale contenant de la sauge | |
| FR3127690B1 (fr) | Produit de combinaison pour soulager les maux de gorges | |
| FR2847815B1 (fr) | Utilisation d'au moins un extrait de miellat de coton comme ingredient actif dans ou pour la preparation d'une composition cosmetique et/ou pharmaceutique. | |
| FR3058065B1 (fr) | Composition pour le traitement d’une affection de l’appareil locomoteur | |
| Chierakul | Update on treatment of melioidosis | |
| FR3125706B1 (fr) | Produit de combinaison pour stimuler le fonctionnement des cellules hépatiques et faciliter l’endormissement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20210101 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |